Private equity investment focused on healthcare, real estate, and natural resources

my mhealth develops and commercializes digital therapeutics for long-term conditions. We're a UK-based team of doctors, engineers, product designers and digital health advocates creating digital therapeutics and services that help people living with COPD, heart disease, asthma, diabetes and cancer. We work with the NHS, global health services, insurers, pharma and life science businesses to create innovative digital solutions that put patients in control of their care.

Click Therapeutics, Inc. develops and commercializes software as prescription medical treatments. Click created the term Digital Therapeutics in 2012 based on the premise that mobile software can be an effective treatment for people with unmet medical needs. Through cognitive and neurobehavioral mechanisms, Click Therapeutics' digital interventions enable change within individuals, and can be used independently or in conjunction with biomedical treatments. The Clickometrics® adaptive data science platform continuously personalizes user experience to optimize engagement and outcomes. As the leader in Digital Therapeutics™ solutions, Click Therapeutics is building the brains behind digital medicine.

Accountable Care Organizations - The ACO NetworkGo here to join the group: https://www.linkedin.com/groups/3859475This LinkedIn Group was created to explore and discuss trends in healthcare delivery towards "Accountable Care". In an open exchange format the group provides a venue for continuous learning and discussion among 1000+ payer, provider, supplier, and healthcare consultant executives.

Zillion was established in 2014 as a telehealth company to improve people’s wellbeing by emphasizing their individual lifestyle choices, with support from relevant digital and human interaction. Rather than offering canned content for broad health solutions, Zillion, through our technology, focuses on care, coaching, and health recommendations that precisely address individuals’ conditions, goals, and lifestyles. Modifying human choices with relevant personal interactions creates sustained, long-lasting change required for positive health outcomes. Positive health outcomes can be achieved through our platform, Zillion SaaS for a company looking to bring their programs to life, or our own proprietary wellbeing programs, RestoreHealth or RestoreResilience.We launched the Zillion technology platform to simplify the way they connect, enabling faster, cost-effective engagements.

Option Care Enterprises, Inc., formerly Walgreens Infusion Services, Inc., offers clinical care provided by specially trained infusion nurses, pharmacists and dietitians who treat patients with a wide range of acute, chronic and rare conditions. As one of the nation’s largest providers of home and alternate treatment site infusion services, Option Care has 92 infusion pharmacies and 110 alternate treatment sites across the country.

This Johnson & Johnson subsidiary is the medical device and diagnostics hub of J&J focused on surgical and office based “buy and bill” medical devices used in orthopaedic surgery and sports medicine.

A biopharmaceutical company focused on developing and commercializing novel agents addressing the therapeutic limitations of conventional cancer therapies.

An on-demand molecular diagnostics company that develops, manufactures, and markets fully-integrated systems and tests for genetic analysis in the clinical, industrial and biothreat markets.

Cardiovascular operating hub within the Johnson & Johnson family of companies.

A leading pharmaceutical manufacturer, formerly Rhone-Poulenc Rorer and Aventis Pharmaceuticals.